Skip to main content

Inotiv, Inc.

NOTVDelisted Jul 10, 2026
Industry
Services-Commercial Physical & Biological Research
SEC CIK
0000720154

Inotiv, Inc. was delisted on Jul 10, 2026; its insiders filed their last Form 4 on Jul 20, 2026; 51 institutions reported holding it in 13F filings for Q1 2026, worth $1.39M in total; no superinvestor held it.

Currency
USD
Source
SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
Updated
Oct 8, 2026, 11:27 AM ET

Revenue flow, FY2025

Where the revenue went in FY2025, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.

Net loss for FY2025: $68.6M (13.4% of revenue).

Income statement

Each column is one fiscal year, newest first.

Income statement of Inotiv, Inc., annual
Line itemFY2025FY2024FY2023FY2022FY2021
Period endSep 30, 2025Sep 30, 2024Sep 30, 2023Sep 30, 2022Sep 30, 2021
Filing10-K10-K10-K10-K10-K
ReportedNov 17, 2025Dec 3, 2024Dec 11, 2023Dec 12, 2022Dec 7, 2021
Revenue$513.0M$490.7M$572.4M$547.7M$89.6M
Cost of revenue––––$59.4M
Gross profit––––$30.2M
Operating expenses––––$35.8M
Research and development––––$405.0K
Selling, general and administrative$71.1M$77.0M$108.2M$82.4M$30.4M
Operating income-$30.9M-$86.4M-$81.5M-$263.5M-$5.62M
Interest expense––$43.0M$29.7M$1.68M
Income tax-$19.1M-$21.9M-$19.3M-$15.2M-$4.78M
Net income-$68.6M-$108.4M-$105.1M-$337.0M$10.9M
EPS, basic$-2.11$-4.19$-4.10$-13.84$0.83
EPS, diluted$-2.11$-4.19$-4.10$-13.84$0.19
Weighted shares, basic32.5M25.9M25.6M24.4M13.2M
Weighted shares, diluted32.5M25.9M25.6M24.4M13.9M
Margins and growth
Gross margin––––33.7%
Operating margin-6.0%-17.6%-14.2%-48.1%-6.3%
Net margin-13.4%-22.1%-18.4%-61.5%12.2%
Revenue growth, year over year+4.5%−14.3%+4.5%+511.2%+48.2%
Net income growth, year over year–––−3,193.3%–

Balance sheet

Each column is one fiscal year, newest first.

Balance sheet of Inotiv, Inc., annual
Line itemFY2025FY2024FY2023FY2022FY2021
Period endSep 30, 2025Sep 30, 2024Sep 30, 2023Sep 30, 2022Sep 30, 2021
Filing10-K10-K10-K10-K10-K
ReportedNov 17, 2025Dec 3, 2024Dec 11, 2023Dec 12, 2022Dec 7, 2021
Cash and equivalents$21.7M$21.4M$35.5M$18.5M$138.9M
Accounts receivable–––$88.9M$20.7M
Inventory$45.7M$18.2M$56.1M$71.4M$602.0K
Total current assets$194.6M$163.4M$213.8M$233.0M$189.0M
Property, plant and equipment$180.7M$188.3M$191.1M$186.2M$48.0M
Goodwill$94.3M$94.3M$94.3M$157.8M$51.9M
Intangible assets$240.2M$274.4M$308.4M$345.9M$24.2M
Total assets$771.1M$781.4M$856.5M$962.9M$321.9M
Accounts payable$48.5M$33.5M$32.6M$28.7M$6.16M
Short-term debt$402.1M$3.54M$7.95M$7.98M$9.66M
Total current liabilities$556.8M$119.0M$132.2M$164.1M$55.1M
Long-term debt$0$389.8M$369.8M$330.7M$154.2M
Total liabilities$635.1M$610.9M$588.0M$603.1M$216.7M
Shareholders' equity$136.0M$170.5M$268.5M$359.8M$105.1M

Cash flow statement

Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.

Cash flow statement of Inotiv, Inc., annual
Line itemFY2025FY2024FY2023FY2022FY2021
Period endSep 30, 2025Sep 30, 2024Sep 30, 2023Sep 30, 2022Sep 30, 2021
Filing10-K10-K10-K10-K10-K
ReportedNov 17, 2025Dec 3, 2024Dec 11, 2023Dec 12, 2022Dec 7, 2021
Operating cash flow-$10.5M-$6.80M$27.9M-$5.22M$10.7M
Capital expenditures$16.6M$22.3M$27.5M$36.3M$12.5M
Free cash flow-$27.1M-$29.1M$380.0K-$41.5M-$1.73M
Depreciation and amortization$55.9M$57.1M$54.7M$49.3M$6.27M
Stock-based compensation$6.03M$6.74M$7.84M$24.2M$1.79M
Investing cash flow-$12.9M-$16.8M-$28.8M-$333.7M-$54.1M
Financing cash flow$23.7M$9.68M$15.9M$203.2M$198.8M
Net change in cash$309.0K-$14.1M$16.5M-$137.9M$155.5M
Ratio
Stock-based compensation, % of revenue1.2%1.4%1.4%4.4%2.0%

Shares outstanding

Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.

Shares outstanding for Inotiv, Inc. by cover date
Cover dateShares outstandingChange in a yearFiling
Apr 16, 202634.9M+1.6%SEC
Jan 23, 202634.4M+1.6%SEC
Jan 20, 202634.4M+1.6%SEC
Nov 21, 202534.4M+32.1%SEC
Jul 31, 202534.4M+32.1%SEC
Apr 30, 202534.4M+32.3%SEC
Jan 30, 202533.9M+31.3%SEC
Nov 15, 202426.0M+0.9%SEC

Notes and known gaps

How these numbers are put together, and what they can't tell you.

  • Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
  • Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.

Known gaps

  • Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
  • EPS and share counts are as reported at the time, not adjusted for later stock splits.
  • For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
  • For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
  • Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
  • Depreciation and amortization is missing for some companies that report it under their own XBRL tags.